Methods For Treating Pancreatic Cancer Using Combination Therapies
US-2026000666-A1 · Jan 1, 2026 · US
This page is not indexed by search engines while we improve data quality.
Fitzgerald Jonathan Basil patents
Fitzgerald Jonathan Basil is listed as an inventor on 56 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Fitzgerald Jonathan Basil |
| Total patents | 56 |
| First publication | Jul 2, 2015 |
| Latest publication | Jan 1, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
US-2025381191-A1 · Dec 18, 2025 · US
Methods for treating pancreatic cancer using combination therapies
US-12364691-B2 · Jul 22, 2025 · US
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
US-2024358706-A1 · Oct 31, 2024 · US
Methods For Treating Pancreatic Cancer Using Combination Therapies
US-2024342162-A1 · Oct 17, 2024 · US
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
US-2024226090-A1 · Jul 11, 2024 · US
Combination therapy for cancer treatment
US-11844795-B2 · Dec 19, 2023 · US
Methods For Treating Pancreatic Cancer Using Combination Therapies
US-2023088999-A1 · Mar 23, 2023 · US
Combination Therapy for Cancer Treatment
US-2023074866-A1 · Mar 9, 2023 · US
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
US-2023062425-A1 · Mar 2, 2023 · US
Recent patents
Latest publications not already listed above.
Nanoliposomal Irinotecan for Use in Treating Small Cell Lung Cancer
US-2023000858-A1 · Jan 5, 2023 · US
Methods for treating pancreatic cancer using combination therapies
US-11369597-B2 · Jun 28, 2022 · US
Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin
US-11344552-B2 · May 31, 2022 · US
Nanoliposomal irinotecan for use in treating small cell lung cancer
US-11318131-B2 · May 3, 2022 · US
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
US-2022096458-A1 · Mar 31, 2022 · US
Treating gastric cancer using combination therapies comprising liposomal irinotecan, oxaliplatin, 5-fluorouracil (and leucovorin)
US-11071726-B2 · Jul 27, 2021 · US
Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
US-10980795-B2 · Apr 20, 2021 · US
Treatment of Breast Cancer with Liposomal Irinotecan
US-2020360367-A1 · Nov 19, 2020 · US
Combination Therapy for Cancer Treatment
US-2020268742-A1 · Aug 27, 2020 · US
Treating Gastric Cancer Using Combination Therapies Comprising Liposomal Irinotecan, Oxaliplatin, 5-Fluoruracil (and Leucovorin)
US-2020030302-A1 · Jan 30, 2020 · US
Combination therapy for cancer treatment
US-10478428-B2 · Nov 19, 2019 · US
Nanoliposomal Irinotecan for Use in Treating Small Cell Lung Cancer
US-2019167661-A1 · Jun 6, 2019 · US
Treatment of Breast Cancer with Liposomal Irinotecan
US-2019142822-A1 · May 16, 2019 · US
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
US-2019117643-A1 · Apr 25, 2019 · US
Methods For Treating Pancreatic Cancer Using Combination Therapies
US-2019117644-A1 · Apr 25, 2019 · US
Combination therapy for cancer treatment
US-2018117034-A1 · May 3, 2018 · US
Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies
US-9938346-B2 · Apr 10, 2018 · US
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
US-2018078556-A1 · Mar 22, 2018 · US
Combination therapy for cancer treatment
US-9895365-B2 · Feb 20, 2018 · US
Methods for Treating Pancreatic Cancer Using Combination Therapies
US-2018008591-A1 · Jan 11, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ipsen Biopharm Ltd | 32 |
| Merrimack Pharmaceuticals Inc | 24 |
| Ispen Biopharm Ltd | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K9/0019 | 49 |
| A61K31/4745 | 49 |
| A61K9/127 | 47 |
| A61P35/00 | 46 |
| A61K9/1271 | 43 |